Dimensional Fund Advisors LP boosted its stake in DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 23.6% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 822,314 shares of the company's stock after buying an additional 156,841 shares during the quarter. Dimensional Fund Advisors LP owned approximately 0.41% of DocuSign worth $73,975,000 as of its most recent filing with the SEC.
A number of other large investors have also recently bought and sold shares of the stock. Rhumbline Advisers lifted its position in shares of DocuSign by 118.8% in the fourth quarter. Rhumbline Advisers now owns 608,123 shares of the company's stock valued at $54,695,000 after acquiring an additional 330,136 shares in the last quarter. KBC Group NV raised its stake in DocuSign by 32.7% in the 4th quarter. KBC Group NV now owns 1,535,107 shares of the company's stock valued at $138,067,000 after purchasing an additional 378,233 shares during the last quarter. Jennison Associates LLC purchased a new position in DocuSign in the 4th quarter valued at about $12,897,000. Everence Capital Management Inc. acquired a new stake in shares of DocuSign during the 4th quarter worth about $720,000. Finally, Principal Financial Group Inc. grew its holdings in shares of DocuSign by 3,026.7% during the fourth quarter. Principal Financial Group Inc. now owns 546,796 shares of the company's stock worth $49,179,000 after buying an additional 529,308 shares in the last quarter. Institutional investors and hedge funds own 77.64% of the company's stock.
DocuSign Trading Down 0.4 %
DOCU traded down $0.33 during trading on Tuesday, hitting $82.12. 138,517 shares of the company's stock were exchanged, compared to its average volume of 2,735,748. DocuSign, Inc. has a 1 year low of $48.70 and a 1 year high of $107.86. The stock has a 50 day moving average price of $80.08 and a 200 day moving average price of $84.24. The firm has a market cap of $16.63 billion, a P/E ratio of 16.97, a price-to-earnings-growth ratio of 6.94 and a beta of 1.21.
DocuSign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings results on Thursday, March 13th. The company reported $0.86 earnings per share for the quarter, topping analysts' consensus estimates of $0.84 by $0.02. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The firm had revenue of $776.25 million during the quarter, compared to analysts' expectations of $760.94 million. During the same period in the prior year, the company earned $0.76 EPS. The firm's revenue was up 9.0% on a year-over-year basis. Analysts forecast that DocuSign, Inc. will post 1.17 earnings per share for the current fiscal year.
Insider Activity
In other news, CFO Blake Jeffrey Grayson sold 8,000 shares of the company's stock in a transaction on Tuesday, April 15th. The shares were sold at an average price of $76.09, for a total value of $608,720.00. Following the completion of the transaction, the chief financial officer now directly owns 86,156 shares in the company, valued at approximately $6,555,610.04. This represents a 8.50 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Teresa Briggs sold 534 shares of DocuSign stock in a transaction on Monday, March 17th. The stock was sold at an average price of $87.41, for a total transaction of $46,676.94. Following the sale, the director now directly owns 8,270 shares in the company, valued at $722,880.70. This trade represents a 6.07 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 55,851 shares of company stock worth $4,607,439. 1.66% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
DOCU has been the topic of several recent analyst reports. JPMorgan Chase & Co. raised shares of DocuSign from an "underweight" rating to a "neutral" rating and upped their price objective for the company from $70.00 to $75.00 in a research note on Monday, March 10th. Jefferies Financial Group decreased their price objective on DocuSign from $115.00 to $105.00 and set a "buy" rating on the stock in a report on Monday, March 31st. Hsbc Global Res upgraded DocuSign from a "moderate sell" rating to a "hold" rating in a research note on Friday, April 11th. UBS Group reduced their target price on DocuSign from $90.00 to $85.00 and set a "neutral" rating on the stock in a research report on Thursday, April 17th. Finally, JMP Securities restated a "market outperform" rating and issued a $124.00 price target on shares of DocuSign in a report on Thursday, April 17th. One equities research analyst has rated the stock with a sell rating, eleven have issued a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $92.46.
View Our Latest Stock Report on DocuSign
DocuSign Profile
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Stories

Before you consider DocuSign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.
While DocuSign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.